Birchler Brian's Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Jan 17, 2025
- Accession no.
- 0000874015-25-000057
- Filed
- Jan 17, 2025
- Trade date
- Jan 15-16, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market sales total $176.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Birchler BrianCIK 0001970151 | Officer (EVP, Corp and Development Ops) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2025 | Common Stock | MOption exerciseAcquired | +14,283 | $0.00 | $0 | 60,451 | Direct | |
| Jan 16, 2025 | Common Stock | SSaleDisposed | −5,400 | $32.70 | −$176,580 | 55,051 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2025 | Common Stock | AGrant or awardAcquired | +22,000 | $0.00 | $0 | 53,338 | Direct | |
| Jan 15, 2025 | Common Stock | AGrant or awardAcquired | +33,000 | $0.00 | $0 | 77,373 | Direct | |
| Jan 15, 2025 | Common Stock | MOption exerciseDisposed | −14,283 | $0.00 | $0 | 63,090 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.